Jeremy Bass, - Medicare Anesthesiology Assistant in Mobile, AL

Jeremy Bass, is a medicare enrolled "Anesthesiologist Assistant" in Mobile, Alabama. He graduated from nursing school in 2015 and has 7 years of diverse experience with area of expertise as Anesthesiology Assistant. He is a member of the group practice Anesthesiologists Associated Pc and his current practice location is 5 Mobile Infirmary Cir, Mobile, Alabama. You can reach out to his office (for appointments etc.) via phone at (251) 435-2400.

Jeremy Bass is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1932578069.

Contact Information

Jeremy Bass,
5 Mobile Infirmary Cir,
Mobile, AL 36607-3513
(251) 435-2400
Not Available



Provider's Profile

Full NameJeremy Bass
GenderMale
SpecialityAnesthesiology Assistant
Experience7 Years
Location5 Mobile Infirmary Cir, Mobile, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jeremy Bass graduated from nursing school in 2015
  NPI Data:
  • NPI Number: 1932578069
  • Provider Enumeration Date: 09/18/2015
  • Last Update Date: 09/18/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 2466752449
  • Enrollment ID: I20151123002195

Medical Identifiers

Medical identifiers for Jeremy Bass such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1932578069NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367H00000XAnesthesiologist Assistant (* (Not Available))Primary

Hospital Affiliation

Hospital NameLocationType
Mobile Infirmary Medical CenterMobile, ALAcute Care Hospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Anesthesiologists Associated Pc6204739519345

News Archive

Repligen receives $731,000 to support ongoing development of new treatments for Friedreich's ataxia

Repligen Corporation today announced that the Company has received $731,000 in research funding to support the ongoing development of new treatments for Friedreich's ataxia from the Muscular Dystrophy Association (MDA).

Lupin gets tentative approval from FDA for Armodafinil Tablets, Doxycycline Capsules

elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jeremy Bass allows following entities to bill medicare on his behalf.
Entity NameAnesthesiologists Associated Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851371850
PECOS PAC ID: 6204739519
Enrollment ID: O20040202000465

News Archive

Repligen receives $731,000 to support ongoing development of new treatments for Friedreich's ataxia

Repligen Corporation today announced that the Company has received $731,000 in research funding to support the ongoing development of new treatments for Friedreich's ataxia from the Muscular Dystrophy Association (MDA).

Lupin gets tentative approval from FDA for Armodafinil Tablets, Doxycycline Capsules

elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows.

Read more Medical News

› Verified 6 days ago

Entity NameAnesthesia Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649265810
PECOS PAC ID: 1557352754
Enrollment ID: O20040518001018

News Archive

Repligen receives $731,000 to support ongoing development of new treatments for Friedreich's ataxia

Repligen Corporation today announced that the Company has received $731,000 in research funding to support the ongoing development of new treatments for Friedreich's ataxia from the Muscular Dystrophy Association (MDA).

Lupin gets tentative approval from FDA for Armodafinil Tablets, Doxycycline Capsules

elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jeremy Bass is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jeremy Bass,
1 Mobile Infirmary Cir, Floor 2,
Mobile, AL 36607-3522

Ph: (251) 435-7990
Jeremy Bass,
5 Mobile Infirmary Cir,
Mobile, AL 36607-3513

Ph: (251) 435-2400

News Archive

Repligen receives $731,000 to support ongoing development of new treatments for Friedreich's ataxia

Repligen Corporation today announced that the Company has received $731,000 in research funding to support the ongoing development of new treatments for Friedreich's ataxia from the Muscular Dystrophy Association (MDA).

Lupin gets tentative approval from FDA for Armodafinil Tablets, Doxycycline Capsules

elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows.

Read more News

› Verified 6 days ago


Anesthesiologist Assistant Nurses in Mobile, AL

Simon M Saliba, AA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607
Phone: 251-432-4497    Fax: 251-432-0577
Kerry Coomer,
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607
Phone: 251-435-2400    
Claudia Rey Casanova, AA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607
Phone: 251-435-2400    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2022 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.